Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Tychy – page 11

1 211 clinical trials in Tychy, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Tychy at a glance
1 211
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 211 trials in Tychy

Open in trial search

Hepatic cirrhosis+2

Recruiting

Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Efruxifermin
  • Sponsor:Akero Therapeutics Inc.

Schizophrenia

Recruiting

Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Vafidemstat
  • Sponsor:Oryzon Genomics S.A.

Cardiac failure

Recruiting

Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Onychomycosis

Recruiting

Study on the Safety and Effectiveness of Terbinafine Solution for Treating Mild to Moderate Nail Fungus in Children Aged 6-17 Years

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Terbinafine
  • Sponsor:Moberg Pharma AB (publ)

Study of Pembrolizumab Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme Patients

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Agencja Badań Medycznych

Study on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma

Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Eikon Therapeutics Inc.

Cardiac failure

Recruiting

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Prostate cancer

Recruiting

Study on Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan for Adults with Prostate Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177LU) vipivotide tetraxetan
  • Sponsor:Novartis Pharma AG

Study on the Effectiveness and Safety of Ademetionine with Antidepressants for Patients with Major Depressive Disorder

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ademetionine
  • Sponsor:Mylan Inc.

Efficacy and Safety of Three Different Doses of Pirtobrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Previously Received BTK Inhibitor Treatment

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pirtobrutinib
  • Sponsor:Eli Lilly & Co.

Alopecia areata

Recruiting

Study of ritlecitinib tosilate for hair regrowth in adults and adolescents (12 years and older) with moderate alopecia areata

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

Efficacy and safety of weekly subcutaneous zenagamtide versus placebo in adults with type 2 diabetes not controlled by diet and exercise

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Tychy

What the registry says about research in the country

01 Gastrointestinal Research

Comprehensive studies focusing on inflammatory bowel diseases, including multiple trials investigating new treatments for Crohn's Disease and Ulcerative Colitis. Research aims at evaluating novel therapeutic approaches for both moderate and severe cases.

  • Crohn's Disease Management
  • Ulcerative Colitis Treatments
  • Eosinophilic Esophagitis Studies

Clinical investigations are examining both established and experimental medications to improve patient outcomes and quality of life.

02 Cardiovascular Studies

Extensive research into heart conditions and related disorders, with particular focus on heart failure, myocardial infarction, and hypertension management. Studies evaluate both new medications and innovative treatment approaches.

  • Heart Failure Therapies
  • Post-Heart Attack Treatment
  • Blood Pressure Management

Trials are investigating both preventive measures and therapeutic interventions for various cardiovascular conditions.

03 Respiratory Research

Innovative studies focusing on respiratory infections and preventive treatments, particularly in vulnerable populations. Research includes evaluation of new preventive therapies for RSV in infants.

  • RSV Prevention
  • Respiratory Infection Management
  • Pediatric Respiratory Care

Clinical trials aim to develop effective preventive measures and treatments for respiratory conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.